Incyte(INCY) - 2024 Q4 - Earnings Call Presentation

2024 Fourth Quarter & Full-Year Financial and Corporate Update February 10th, 2025 Fourth Quarter & FY 2024 Earnings Call Agenda Ben Strain Head of Investor Relations Introduction Hervé Hoppenot Chief Executive Officer Key Highlights & Commercial Review Pablo Cagnoni R&D Update President, Head of Research & Development Christiana Stamoulis Chief Financial Officer Financial Review Available for Q&A Matteo Trotta General Manager, U.S. Dermatology Steven Stein Chief Medical Officer 2 Forward Looking Statements ...